| 2022 | Cost-effectiveness of chronic hepatitis C screening and treatment
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2022 | Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study | JOURNAL OF VIRAL HEPATITIS |
| 2022 | Asian perspective on NAFLD-associated HCC | JOURNAL OF HEPATOLOGY |
| 2022 | Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis
| JHEP REPORTS |
| 2022 | Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
| GUT AND LIVER |
| 2022 | Predictors of Sarcopenia in an Obese Asian Population | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL |
| 2022 | Impact of Exogenous Treatment with Histidine on Hepatocellular Carcinoma Cells
| CANCERS |
| 2022 | External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study
| CANCERS |
| 2022 | Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL | AMERICAN JOURNAL OF GASTROENTEROLOGY |
| 2022 | Metabolic Dysfunction-Associated Fatty Liver Disease Increases Colon Cancer Risk: A Nationwide Cohort Study
| CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY |
| 2022 | Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
| CANCERS |
| 2022 | Long-term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2021 | Secular trend of treatment uptake in patients with chronic hepatitis B: A territory-wide study of 135 395 patients from 2000 to 2017 | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2021 | Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy
| CANCERS |
| 2021 | No influence of hepatic steatosis on the 3-year outcomes of patients with quiescent chronic hepatitis B | JOURNAL OF VIRAL HEPATITIS |
| 2021 | YAP/TAZ Suppress Drug Penetration Into Hepatocellular Carcinoma Through Stromal Activation | HEPATOLOGY |
| 2021 | Current role of systemic therapy in transarterial chemotherapy refractory hepatocellular carcinoma patients
| International Journal of Gastrointestinal Intervention |
| 2021 | Dickkopf-1 promotes angiogenesis by upregulating VEGF receptor 2-mediated mTOR/p70S6K signaling in hepatocellular carcinoma
| AMERICAN JOURNAL OF CANCER RESEARCH |
| 2021 | Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease
| JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE |
| 2021 | Risk assessment of hepatocellular carcinoma and liver-related events using ultrasonography and transient elastography in patients with chronic hepatitis B | JOURNAL OF VIRAL HEPATITIS |
| 2021 | Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B | JOURNAL OF VIRAL HEPATITIS |
| 2021 | Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | HEPATOLOGY INTERNATIONAL |
| 2021 | Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2021 | Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2021 | Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis B | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| 2021 | Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
| CANCERS |
| 2021 | Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy | HEPATOLOGY INTERNATIONAL |
| 2021 | Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2021 | KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2021 | Clinical Characteristics of Long-Term Survivors After Sorafenib Treatment for Unresectable Hepatocellular Carcinoma: A Korean National Multicenter Retrospective Cohort Study
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
| 2021 | Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2021 | Metabolic activity assessment by 18 F-fluorodeoxyglucose positron emission tomography in patients with hepatocellular carcinoma undergoing Yttrium-90 transarterial radioembolization | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2021 | External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals | JOURNAL OF VIRAL HEPATITIS |
| 2021 | Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C
| GUT AND LIVER |
| 2021 | Hepatitis B Core-Related Antigen: From Virology to Clinical Application | SEMINARS IN LIVER DISEASE |
| 2021 | Combination therapy with anti-T-cell immunoglobulin and mucin-domain containing molecule 3 and radiation improves antitumor efficacy in murine hepatocellular carcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2021 | The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
| 2021 | Hepatobiliary and Pancreatic: Liver abscess not responding to drainage and antibiotics | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2021 | Roadmap to resuming care for liver diseases after coronavirus disease-2019
| JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2021 | Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2021 | Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B | HEPATOLOGY RESEARCH |
| 2021 | Artificial intelligence in liver disease | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2021 | A Case of Lymphocyte-Rich Hepatocellular Carcinoma in a Patient Who Was Treated for Colon Cancer
| Journal of Liver Cancer(대한간암학회지) |
| 2021 | Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B | EUROPEAN JOURNAL OF INTERNAL MEDICINE |
| 2021 | Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization
| CURRENT ONCOLOGY |
| 2021 | Hepatitis B Virus Cure: Targets and Future Therapies
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2021 | High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma
| SCIENTIFIC REPORTS |
| 2021 | Patterns and Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Invasion: A Multicenter Prospective Cohort Study | DIGESTIVE DISEASES AND SCIENCES |
| 2021 | Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
| GUT AND LIVER |
| 2021 | Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir | JOURNAL OF VIRAL HEPATITIS |
http://orcid.org/0000-0002-3552-3560
